A Clinical Trial to Evaluate Safety of Vosoritide in At-risk Infants With Achondroplasia
Clinical trial NCT04554940 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04554940
- Sponsor
- BioMarin Pharmaceutical
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-10
- Primary completion
- 2027-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.